Latest Innovive Pharmaceuticals Inc. Stories
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of therapeutics based on molecular chaperone amplification, today reported financial results for the three months ended June 30, 2008 and other second quarter developments. "During the second quarter, we announced the signing of a definitive agreement to purchase Innovive Pharmaceuticals, Inc.," said Steven A. Kriegsman, CytRx President and CEO. "The acquisition is a compelling...
- To talk saucily.
- Insolent, opprobrious language; impertinent abuse.